UBS Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $219M | Buy |
920,950
+81,381
| +10% | +$16.9M | 0.03% | 616 |
|
|
2026
Q1 | $177M | Sell |
839,569
-129,278
| -13% | -$27.8M | 0.03% | 671 |
|
|
2025
Q4 | $199M | Sell |
968,847
-35,452
| -4% | -$6.67M | 0.03% | 580 |
|
|
2025
Q3 | $158M | Buy |
1,004,299
+29,169
| +3% | +$4.51M | 0.02% | 714 |
|
|
2025
Q2 | $164M | Buy |
975,130
+39,760
| +4% | +$5.9M | 0.03% | 639 |
|
|
2025
Q1 | $129M | Sell |
935,370
-36,780
| -4% | -$4.69M | 0.02% | 764 |
|
|
2024
Q4 | $115M | Sell |
972,150
-327,859
| -25% | -$38.3M | 0.02% | 832 |
|
|
2024
Q3 | $144M | Buy |
1,300,009
+461,626
| +55% | +$48.3M | 0.03% | 554 |
|
|
2024
Q2 | $82.4M | Buy |
838,383
+33,430
| +4% | +$3.41M | 0.02% | 743 |
|
|
2024
Q1 | $90.1M | Buy |
804,953
+369,266
| +85% | +$39.8M | 0.02% | 703 |
|
|
2023
Q4 | $43.9M | Buy |
435,687
+10,959
| +3% | +$1.09M | 0.01% | 1061 |
|
|
2023
Q3 | $36.9M | Sell |
424,728
-39,146
| -8% | -$3.54M | 0.01% | 1033 |
|
|
2023
Q2 | $43.9M | Sell |
463,874
-44,727
| -9% | -$3.78M | 0.01% | 906 |
|
|
2023
Q1 | $38.4M | Sell |
508,601
-11,088
| -2% | -$837K | 0.01% | 928 |
|
|
2022
Q4 | $39.9M | Sell |
519,689
-1,894
| -0.4% | -$144K | 0.01% | 935 |
|
|
2022
Q3 | $34.8M | Sell |
521,583
-325,179
| -38% | -$20.6M | 0.02% | 908 |
|
|
2022
Q2 | $44.3M | Buy |
846,762
+94,547
| +13% | +$5.37M | 0.02% | 795 |
|
|
2022
Q1 | $42.6M | Buy |
752,215
+98,409
| +15% | +$5.27M | 0.01% | 936 |
|
|
2021
Q4 | $33.7M | Buy |
653,806
+56,878
| +10% | +$2.79M | 0.01% | 1214 |
|
|
2021
Q3 | $29.5M | Sell |
596,928
-106,671
| -15% | -$5.79M | 0.01% | 1193 |
|
|
2021
Q2 | $40.2M | Sell |
703,599
-20,223
| -3% | -$1.18M | 0.01% | 982 |
|
|
2021
Q1 | $44M | Sell |
723,822
-6,568
| -0.9% | -$363K | 0.01% | 918 |
|
|
2020
Q4 | $39.1M | Sell |
730,390
-58,415
| -7% | -$3.03M | 0.01% | 925 |
|
|
2020
Q3 | $37M | Buy |
788,805
+242,212
| +44% | +$12.4M | 0.01% | 810 |
|
|
2020
Q2 | $28.5M | Sell |
546,593
-129,851
| -19% | -$6.69M | 0.01% | 880 |
|
|
2020
Q1 | $32.4M | Buy |
676,444
+43,313
| +7% | +$2.25M | 0.02% | 743 |
|
|
2019
Q4 | $32M | Sell |
633,131
-7,985
| -1% | -$412K | 0.01% | 1048 |
|
|
2019
Q3 | $30.3M | Buy |
641,116
+147,683
| +30% | +$6.74M | 0.01% | 968 |
|
|
2019
Q2 | $23.2M | Buy |
493,433
+14,434
| +3% | +$666K | 0.01% | 1115 |
|
|
2019
Q1 | $23.1M | Buy |
478,999
+99,200
| +26% | +$4.97M | 0.01% | 1065 |
|
|
2018
Q4 | $16.9M | Sell |
379,799
-106,024
| -22% | -$5.53M | 0.01% | 1198 |
|
|
2018
Q3 | $26.2M | Buy |
485,823
+23,288
| +5% | +$1.19M | 0.01% | 1029 |
|
|
2018
Q2 | $22.6M | Sell |
462,535
-46,806
| -9% | -$2.65M | 0.01% | 1091 |
|
|
2018
Q1 | $31.9M | Sell |
509,341
-35,332
| -6% | -$2.42M | 0.01% | 857 |
|
|
2017
Q4 | $33.4M | Buy |
544,673
+200,502
| +58% | +$12.4M | 0.01% | 866 |
|
|
2017
Q3 | $23M | Buy |
344,171
+27,166
| +9% | +$1.92M | 0.01% | 1025 |
|
|
2017
Q2 | $24.7M | Sell |
317,005
-213,816
| -40% | -$16.1M | 0.01% | 920 |
|
|
2017
Q1 | $43.3M | Buy |
530,821
+144,666
| +37% | +$11.4M | 0.02% | 605 |
|
|
2016
Q4 | $27.8M | Buy |
386,155
+40,668
| +12% | +$2.94M | 0.02% | 826 |
|
|
2016
Q3 | $26.8M | Sell |
345,487
-107,142
| -24% | -$8.66M | 0.02% | 799 |
|
|
2016
Q2 | $35.3M | Sell |
452,629
-122,044
| -21% | -$9.73M | 0.02% | 640 |
|
|
2016
Q1 | $47.1M | Sell |
574,673
-81,673
| -12% | -$6.64M | 0.03% | 487 |
|
|
2015
Q4 | $58.6M | Buy |
656,346
+188,913
| +40% | +$16M | 0.04% | 460 |
|
|
2015
Q3 | $35.9M | Buy |
467,433
+29,555
| +7% | +$2.47M | 0.03% | 600 |
|
|
2015
Q2 | $36.6M | Sell |
437,878
-86,144
| -16% | -$7.61M | 0.02% | 645 |
|
|
2015
Q1 | $47.3M | Sell |
524,022
-18,089
| -3% | -$1.56M | 0.03% | 526 |
|
|
2014
Q4 | $43.8M | Buy |
+542,111
| New | +$42.8M | 0.03% | 593 |
|
Other funds holding CAH
UBS Group's CAH Position: Q2 2026 in Review
UBS Group increased its Cardinal Health (CAH) stake by 9.7% in Q2 2026, buying an estimated $16.9M and bringing the position to 920,950 shares worth $219M. The position accounts for 0.03% of the portfolio, ranked #616.
UBS Group first reported a position in CAH in Q4 2014 and has held it in 47 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- UBS Group held 920,950 shares of Cardinal Health worth $219M as of Q2 2026.
- UBS Group bought 81,381 Cardinal Health shares in Q2 2026, an estimated $16.9M.
- Cardinal Health made up 0.03% of UBS Group's portfolio in Q2 2026, its #616 holding.
- UBS Group first reported a position in Cardinal Health in Q4 2014 and has held it in 47 quarters since.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.